The use of free beta-hCG in antenatal screening for Down's syndrome (original) (raw)
Stability of free beta-hCG in the routine screening of Down syndrome in the first trimester of pregnancy
Drahomira Springer
Prague medical report
View PDFchevron_right
First trimester screening for Down syndrome using free β hCG, total hCG and PAPP-A: an exploratory study
Kevin Spencer
Prenatal Diagnosis, 2007
View PDFchevron_right
A new simple and rapid dual assay for AFP and free β hCG in screening for Down syndrome
Ulf-Håkan Stenman
Clinical Genetics, 2008
View PDFchevron_right
Second-trimester maternal serum screening for Down's syndrome: free beta-human chorionic gonadotrophin (HCG) and alpha-fetoprotein, with or without unconjugated oestriol, compared with total HCG, alpha- fetoprotein and unconjugated oestriol
Bernadette Mermillod
Human Reproduction, 1998
View PDFchevron_right
Between-Method Variation in Human Chorionic Gonadotropin Test Results
George Cembrowski
View PDFchevron_right
Hyperglycosylated Human Chorionic Gonadotropin (Invasive Trophoblast Antigen) Immunoassay: A New Basis for Gestational Down Syndrome Screening
Shohreh Shahabi
Clinical Chemistry, 1999
View PDFchevron_right
First Trimester Biochemical Screening for Trisomy 21: The Role of Free β-hCG and Pregnancy Associated Plasma Protein
Lars Breimer
Annals of Clinical Biochemistry, 1995
View PDFchevron_right
Diagnostic accuracy of first-trimester free β HCG and pregnancy-associated plasma protein-A assays
Leo Vankrieken
Annals of Clinical Biochemistry, 2005
View PDFchevron_right
Serum screening for Down's syndrome between 8 and 14 weeks of pregnancy
James Densem
BJOG: An International Journal of Obstetrics and Gynaecology, 1996
View PDFchevron_right
Comparison of urinary hyperglycosylated human chorionic gonadotropin concentration with the serum triple screen for Down syndrome detection in high-risk pregnancies
Shohreh Shahabi
American Journal of Obstetrics and Gynecology, 2000
View PDFchevron_right
Detection of Early Pregnancy Forms of Human Chorionic Gonadotropin by Home Pregnancy Test Devices
Marco Miracle
View PDFchevron_right
Human chorionic gonadotropin in pregnancy diagnostics
Gianfranco Cervellin
Clinica Chimica Acta, 2011
View PDFchevron_right
Evaluation of a Dried Blood Spot Assay to Measure Prenatal Screening Markers Pregnancy-Associated Plasma Protein A and Free -Subunit of Human Chorionic Gonadotropin
Kevin Spencer
Clinical Chemistry, 2013
View PDFchevron_right
Elevated second-trimester human chorionic gonadotropin levels in association with poor pregnancy outcome
John Owen
American Journal of Obstetrics and Gynecology, 1994
View PDFchevron_right
The analytical specificity of human chorionic gonadotropin assays determined using WHO International Reference Reagents
Corinne Fantz
Clinica Chimica Acta, 2010
View PDFchevron_right
False-Negative Results in Point-of-Care Qualitative Human Chorionic Gonadotropin (hCG) Devices Due to Excess hCG Core Fragment
Ulf-Håkan Stenman
Clinical Chemistry, 2009
View PDFchevron_right
Meta-analysis of first trimester Down syndrome screening studies: free β-human chorionic gonadotropin significantly outperforms intact human chorionic gonadotropin in a multimarker protocol
Robert Galen
American Journal of Obstetrics and Gynecology, 2007
View PDFchevron_right
eta-analysis of first trimester Down syndrome screening tudies: free -human chorionic gonadotropin significantly utperforms intact human chorionic gonadotropin in a ultimarker protocol
Robert Galen
2007
View PDFchevron_right
Comparison of measured concentration values of biochemical serum markers with two immunoassay systems in first trimester screening for fetal aneuploidy
Philipp Soergel
Archives of Gynecology and Obstetrics, 2012
View PDFchevron_right
Urinary β-core human chorionic gonadotrophin: A new approach to Down's syndrome screening
Ray Iles
Prenatal Diagnosis, 1994
View PDFchevron_right
Maternal Serum Invasive Trophoblast Antigen (Hyperglycosylated hCG) as a Screening Marker for Down Syndrome during the Second Trimester
Raj Pandian
Clinical Chemistry, 2004
View PDFchevron_right
Detection of maternal serum hCG glycoform variants in the second trimester of pregnancies affected by Down syndrome using a lectin immunoassay
Kevin Spencer
Prenatal Diagnosis, 2003
View PDFchevron_right
Falsely Decreased Human Chorionic Gonadotropin (hCG) Results Due to Increased Concentrations of the Free Subunit and the Core Fragment in Quantitative hCG Assays
Daniel Hoefner
Clinical Chemistry, 2010
View PDFchevron_right
USA hCG reference service, 10-year report
Carolyn Muller
Clinical Biochemistry, 2010
View PDFchevron_right
Comparison of First Trimester Screening for Down's Syndrome Using Free Beta-Human Chorionic Gonadotropin and Pregnancy-Associated Plasma Protein-A Levels between Spontaneous and IVF Pregnancies at 12 Weeks of Gestation
Marzieh Zamaniyan, international journal of fertility and sterility Int J Fertil Steril
Volume 13, Number 2, Jul-Sep 2019 Pages: 93-96, 2019
View PDFchevron_right
Lack of correlation between elevated maternal serum hCG during second-trimester biochemical screening and fetal congenital anomaly
Claudio Celentano
Prenatal Diagnosis, 2005
View PDFchevron_right
Immunoprocedures for detecting human chorionic gonadotropin: clinical aspects and doping control
Ulf-Håkan Stenman
Clinical chemistry, 1997
View PDFchevron_right
Is maternal serum total hCG a marker of trisomy 21 in the first trimester of pregnancy?
Kevin Spencer
Prenatal Diagnosis, 2000
View PDFchevron_right
First trimester maternal serum screening for Down's syndrome: an evaluation of the DPC Immulite 2000 free β-hCG and pregnancy-associated plasma protein-A assays
Kevin Spencer
Annals of Clinical Biochemistry: International Journal of Laboratory Medicine, 2005
View PDFchevron_right
Hyperglycosylated hCG (invasive trophoblast antigen, ITA) a key antigen for early pregnancy detection
Nicole Stephens
Clinical Biochemistry, 2003
View PDFchevron_right
Differences in Recognition of the 1st WHO International Reference Reagents for hCG-Related Isoforms by Diagnostic Immunoassays for Human Chorionic Gonadotropin
Jean-Michel Bidart
Clinical Chemistry, 2009
View PDFchevron_right